Inactivation of PTEN, a negative regulator of PI3K-AKT, was suggested to contribute to PI3K-AKT hyperactivation in BL [11], although functional consequences of PTEN knockdown have never been investigated in BL cell lines. The gene discussed is AKT1; the disease is Burkitt lymphoma.